HENDERSON, Nev., April 29, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces a major technical milestone with the successful detection of nucleosomes in capillary blood from critically ill sepsis patients...
Hence then, the article about volition announces breakthrough finger prick detection of nucleosomes expanding global market potential for sepsis testing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing )
Also on site :
- Amazon’s $35 Seersucker Comforter Set Has a 'Cloud-Like Feel' That 'Makes You Want to Stay in Bed All Day'
- Today's NYT Mini Crossword Answers for April 29 – CNET
- MI vs SRH Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- IPL 2026, Match 41